|
1
|
Wang Y, Liu Y, Zhu Y, Yu F, Zhao R, Lai X, Jiang H, Xu T, Zhao Y, Zhang R. Investigation of In Vitro Cytocompatibility of Zinc-Containing Coatings Developed on Medical Magnesium Alloys. Materials (Basel) 2023; 17:209. [PMID: 38204062 PMCID: PMC10779706 DOI: 10.3390/ma17010209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Revised: 12/25/2023] [Accepted: 12/28/2023] [Indexed: 01/12/2024]
Abstract
In a neutral solution, we investigated the effects of Na2[ZnEDTA] concentrations at 0, 6, 12, 18, and 24 g/L on surface morphology, chemical composition, degradation resistance, and in vitro cytocompatibility of micro-arc oxidation (MAO) coatings developed on WE43 (Mg-Y-Nd-Zr) magnesium alloys. The results show that the enhanced Na2[ZnEDTA] concentration increased the Zn amount but slightly decreased the degradation resistance of MAO-treated coatings. Among the zinc-containing MAO samples, the fabricated sample in the base solution added 6 g/L Na2[ZnEDTA] exhibits the smallest corrosion current density (6.84 × 10-7 A·cm-2), while the sample developed in the solution added 24 g/L Na2[ZnEDTA] and contains the highest Zn content (3.64 wt.%) but exhibits the largest corrosion current density (1.39 × 10-6 A·cm-2). Compared to untreated WE43 magnesium alloys, zinc-containing MAO samples promote initial cell adhesion and spreading and reveal enhanced cell viability. Coating degradation resistance plays a more important role in osseogenic ability than Zn content. Among the untreated WE43 magnesium alloys and the treated MAO samples, the sample developed in the base solution with 6 g/L Na2[ZnEDTA] reveals the highest ALP expression at 14 d. Our results indicate that the MAO samples formed in the solution with Na2[ZnEDTA] promoted degradation resistance and osseogenesis differentiation of the WE43 magnesium alloys, suggesting potential clinic applications.
Collapse
Affiliation(s)
- Yun Wang
- School of Materials and Energy, Jiangxi Science and Technology Normal University, Nanchang 330013, China; (Y.W.); (Y.Z.); (R.Z.); (X.L.); (H.J.); (T.X.)
| | - Yuzhi Liu
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China;
| | - Yuanyuan Zhu
- School of Materials and Energy, Jiangxi Science and Technology Normal University, Nanchang 330013, China; (Y.W.); (Y.Z.); (R.Z.); (X.L.); (H.J.); (T.X.)
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China;
- R & D Department, Zhejiang Ruigu Biotechnology Co., Ltd., Hangzhou 311121, China
| | - Fanglei Yu
- Zhejiang Canwell Medical Co., Ltd., Jinhua 321000, China;
| | - Rongfang Zhao
- School of Materials and Energy, Jiangxi Science and Technology Normal University, Nanchang 330013, China; (Y.W.); (Y.Z.); (R.Z.); (X.L.); (H.J.); (T.X.)
| | - Xinying Lai
- School of Materials and Energy, Jiangxi Science and Technology Normal University, Nanchang 330013, China; (Y.W.); (Y.Z.); (R.Z.); (X.L.); (H.J.); (T.X.)
| | - Haijun Jiang
- School of Materials and Energy, Jiangxi Science and Technology Normal University, Nanchang 330013, China; (Y.W.); (Y.Z.); (R.Z.); (X.L.); (H.J.); (T.X.)
| | - Tianhong Xu
- School of Materials and Energy, Jiangxi Science and Technology Normal University, Nanchang 330013, China; (Y.W.); (Y.Z.); (R.Z.); (X.L.); (H.J.); (T.X.)
| | - Ying Zhao
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China;
| | - Rongfa Zhang
- School of Materials and Energy, Jiangxi Science and Technology Normal University, Nanchang 330013, China; (Y.W.); (Y.Z.); (R.Z.); (X.L.); (H.J.); (T.X.)
| |
Collapse
|